Profile
Mr. Pär Ribbner is on the Board of Directors at Fluicell AB.
Mr. Ribbner was previously employed as Chief Executive Officer by TiFiC AB, a Principal by AstraZeneca AB, a Principal by LM Ericsson Telefon AB, a Principal by Telia AB, and a Principal by Volvo AB.
He received his undergraduate degree from IHM Business School AB.
Former positions of Pär Ribbner
Companies | Position | End |
---|---|---|
FLUICELL AB | Director/Board Member | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
ERICSSON | Corporate Officer/Principal | - |
AB VOLVO | Corporate Officer/Principal | - |
Telia AB | Corporate Officer/Principal | - |
Training of Pär Ribbner
IHM Business School AB | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
AB VOLVO | Producer Manufacturing |
ERICSSON | Electronic Technology |
FLUICELL AB | Health Technology |
Private companies | 3 |
---|---|
TiFiC AB
TiFiC AB Packaged SoftwareTechnology Services TiFiC AB provides enterprise management and support automation software solutions. Its solutions have helped numerous enterprise service desks and managed service providers assisting the enterprise, consumer and mobile market to streamline their technical support which has led to reduced support costs and increased customer satisfaction. The company was founded by Mats Nordahl and Johan Niclas Attby in 1999 and is headquartered in Gothenburg, Sweden. | Technology Services |
Telia AB | Communications |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Pär Ribbner